New 3D tissue model offers a breakthrough tool for understanding and treating scleroderma and other fibrotic diseases.

One double lung transplant recipient offers advice to former UFC fighter Ben Askren after his surgery, while a doctor ...

A novel prediction model estimated 2-year PFS for adults with early-stage classic Hodgkin lymphoma based on four “readily ...

Artificial intelligence and machine learning are transforming acute respiratory distress syndrome (ARDS) management, enabling ...

For the 300,000 Americans living with the immune disease scleroderma, better treatments can't come soon enough. The rare and ...

Using skin and blood samples from scleroderma patients, the team grew lab-based skin: pinkish, pancake-like, little disks of ...

Rock legend Ozzy Osbourne shared a harrowing prediction about his death, two years before he tragically passed after his ...

Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...

In 2025, Turbine took the first steps in opening its powerful cell simulation platform to the wider drug development ...

Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunomodulation platform designed to restore innate immune function, is excited ...